217 related articles for article (PubMed ID: 31588710)
21. Casein kinase-II inhibition promotes retinal ganglion cell survival and axonal regeneration.
Cen LP; Liu YF; Ng TK; Luo JM; van Rooijen N; Zhang M; Pang CP; Cui Q
Exp Eye Res; 2018 Dec; 177():153-159. PubMed ID: 30118655
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1
Chojnacki K; Wińska P; Karatsai O; Koronkiewicz M; Milner-Krawczyk M; Wielechowska M; Rędowicz MJ; Bretner M; Borowiecki P
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200807
[TBL] [Abstract][Full Text] [Related]
23. Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT.
Yde CW; Frogne T; Lykkesfeldt AE; Fichtner I; Issinger OG; Stenvang J
Cancer Lett; 2007 Oct; 256(2):229-37. PubMed ID: 17629615
[TBL] [Abstract][Full Text] [Related]
24. Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro.
Zembrzuska K; Ostrowski RP; Matyja E
Oncol Rep; 2019 May; 41(5):2703-2716. PubMed ID: 30896865
[TBL] [Abstract][Full Text] [Related]
25. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
[TBL] [Abstract][Full Text] [Related]
26. In Vitro and in Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2.
Haidar S; Aichele D; Birus R; Hielscher J; Laitinen T; Poso A; Jose J
Molecules; 2019 Apr; 24(7):. PubMed ID: 30965682
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity.
Łukowska-Chojnacka E; Wińska P; Wielechowska M; Poprzeczko M; Bretner M
Bioorg Med Chem; 2016 Feb; 24(4):735-41. PubMed ID: 26778657
[TBL] [Abstract][Full Text] [Related]
28. Treatment of cultured human astrocytes and vascular endothelial cells with protein kinase CK2 inhibitors induces early changes in cell shape and cytoskeleton.
Kramerov AA; Golub AG; Bdzhola VG; Yarmoluk SM; Ahmed K; Bretner M; Ljubimov AV
Mol Cell Biochem; 2011 Mar; 349(1-2):125-37. PubMed ID: 21125314
[TBL] [Abstract][Full Text] [Related]
29. Natural Compounds Isolated from
Haidar S; Jürgens FM; Aichele D; Jagels A; Humpf HU; Jose J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361605
[TBL] [Abstract][Full Text] [Related]
30. Hemoglobin neurotoxicity is attenuated by inhibitors of the protein kinase CK2 independent of heme oxygenase activity.
Chen-Roetling J; Li Z; Regan RF
Curr Neurovasc Res; 2008 Aug; 5(3):193-8. PubMed ID: 18691077
[TBL] [Abstract][Full Text] [Related]
31. Halogenated imidazole derivatives block RNA polymerase II elongation along mitogen inducible genes.
Mikula M; Hanusek K; Paziewska A; Dzwonek A; Rubel T; Bomsztyk K; Ostrowski J
BMC Mol Biol; 2010 Jan; 11():4. PubMed ID: 20078881
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.
Najda-Bernatowicz A; Łebska M; Orzeszko A; Kopańska K; Krzywińska E; Muszyńska G; Bretner M
Bioorg Med Chem; 2009 Feb; 17(4):1573-8. PubMed ID: 19168362
[TBL] [Abstract][Full Text] [Related]
33. Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription.
Tapia JC; Torres VA; Rodriguez DA; Leyton L; Quest AF
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15079-84. PubMed ID: 17005722
[TBL] [Abstract][Full Text] [Related]
34. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
Schneider CC; Hessenauer A; Montenarh M; Götz C
Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628
[TBL] [Abstract][Full Text] [Related]
35. Protein Kinase CK2 Content in GL261 Mouse Glioblastoma.
Ferrer-Font L; Alcaraz E; Plana M; Candiota AP; Itarte E; Arús C
Pathol Oncol Res; 2016 Jul; 22(3):633-7. PubMed ID: 26466942
[TBL] [Abstract][Full Text] [Related]
36. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
[TBL] [Abstract][Full Text] [Related]
37. Effect of Simultaneous Inhibition of Protein Kinase CK2 and Thymidylate Synthase in Leukemia and Breast Cancer Cells.
Wińska P; Skierka K; Łukowska-Chojnacka E; Koronkiewicz M; Cieśla J; Bretner M
Anticancer Res; 2018 Aug; 38(8):4617-4627. PubMed ID: 30061228
[TBL] [Abstract][Full Text] [Related]
38. Antitumoral activity of allosteric inhibitors of protein kinase CK2.
Moucadel V; Prudent R; Sautel CF; Teillet F; Barette C; Lafanechere L; Receveur-Brechot V; Cochet C
Oncotarget; 2011 Dec; 2(12):997-1010. PubMed ID: 22184283
[TBL] [Abstract][Full Text] [Related]
39. A specific inhibitor of protein kinase CK2 delays gamma-H2Ax foci removal and reduces clonogenic survival of irradiated mammalian cells.
Zwicker F; Ebert M; Huber PE; Debus J; Weber KJ
Radiat Oncol; 2011 Feb; 6():15. PubMed ID: 21310046
[TBL] [Abstract][Full Text] [Related]
40. Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.
Nitta RT; Gholamin S; Feroze AH; Agarwal M; Cheshier SH; Mitra SS; Li G
Oncogene; 2015 Jul; 34(28):3688-99. PubMed ID: 25241897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
